Michael J. Fox And Harrison Ford Team Up For New Parkinson’s Disease PSA

Harrison Ford and Michael J. Fox teamed up with the help of Ryan Reynolds’ Maximum Effort to film a new PSA for The Michael J. Fox Foundation for Parkinson’s Research.

Pancreatic Cancer Drug Rasonque’s Price Indicates Sustainability Issue

Thinking about the future, it’s inevitable that other cancer drugs like Rasonque will launch at similar or even higher prices. In the long run, how sustainable is this?

Flu And COVID Vaccines This Season — Here’s Who Needs Them, And When

Flu and COVID vaccines were both reformulated for 2026-2027. Here advice from a doctor regarding who should get them and why, and the timing that maximizes protection.

Here Are The Cheapest Ways To Get GLP-1 Drugs In 2026

One in eight US adults takes a GLP-1. Almost none pay list price. Here’s what every way to get the drugs actually costs in 2026, from $25 copays to $1,349 retail.

Workers Face Open Enrollment Shock As Cost Increase Hits 24-Year High

Employee health benefit costs are expected to rise 8.2% on average in 2027 — the highest increase since 2003 – benefits consultancy Marsh says.

Workers Face Open-Enrollment Shock As Cost Hits 24-Year High

Employee health benefit costs are expected to rise 8.2% on average in 2027 — the highest increase since 2003 — according to estimates.

A Robot That Can Draw Your Blood Is Coming To The U.S.

This week’s edition of InnovationRx looks at Vitestro’s newly authorized robot, Italy’s $10 billion pharma family, this year’s Covid-19 vaccines and more.

Continued Disruption At Federal Preventive Health Panel May Mean Less Coverage

Since USPSTF recommendations guide insurer decisions on what types of preventive care to fully cover, the panel’s ongoing upheaval may lead to coverage limits.

Why Forward Deployed Engineers Are Spreading Into Healthcare

Forward-deployed engineers are spreading across healthcare, changing how software is built and resurfacing old tensions between customization and scale.

Molecular Glue And Cancer Therapy: A New Approach To Lymphoma Treatment

A new molecular glue reprograms the lymphoma protein BCL6 to switch cancer-cell death back on, clearing aggressive tumors in mice in just 11 days.